- Home
- GRCE vs YXT Comparison
GRCE vs YXT Comparison
Compare GRCE & YXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- YXT
- Stock Information
- Founded
- GRCE 2002
- YXT 2011
- Country
- GRCE United States
- YXT China
- Employees
- GRCE N/A
- YXT N/A
- Industry
- GRCE
- YXT
- Sector
- GRCE
- YXT
- Exchange
- GRCE NYSE
- YXT NYSE
- Market Cap
- GRCE 42.4M
- YXT 46.0M
- IPO Year
- GRCE N/A
- YXT 2024
- Fundamental
- Price
- GRCE $3.08
- YXT $0.86
- Analyst Decision
- GRCE Strong Buy
- YXT
- Analyst Count
- GRCE 1
- YXT 0
- Target Price
- GRCE $12.00
- YXT N/A
- AVG Volume (30 Days)
- GRCE 62.2K
- YXT 26.8K
- Earning Date
- GRCE 08-15-2025
- YXT 08-21-2025
- Dividend Yield
- GRCE N/A
- YXT N/A
- EPS Growth
- GRCE N/A
- YXT N/A
- EPS
- GRCE N/A
- YXT N/A
- Revenue
- GRCE N/A
- YXT $45,374,087.00
- Revenue This Year
- GRCE N/A
- YXT N/A
- Revenue Next Year
- GRCE N/A
- YXT N/A
- P/E Ratio
- GRCE N/A
- YXT $1.33
- Revenue Growth
- GRCE N/A
- YXT N/A
- 52 Week Low
- GRCE $1.75
- YXT $0.47
- 52 Week High
- GRCE $4.97
- YXT $11.00
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- YXT N/A
- Support Level
- GRCE N/A
- YXT N/A
- Resistance Level
- GRCE N/A
- YXT N/A
- Average True Range (ATR)
- GRCE 0.00
- YXT 0.00
- MACD
- GRCE 0.00
- YXT 0.00
- Stochastic Oscillator
- GRCE 0.00
- YXT 0.00
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS
Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.